BR112018014042A2 - vírus do tipo orthomyxo da tilápia. - Google Patents

vírus do tipo orthomyxo da tilápia.

Info

Publication number
BR112018014042A2
BR112018014042A2 BR112018014042-2A BR112018014042A BR112018014042A2 BR 112018014042 A2 BR112018014042 A2 BR 112018014042A2 BR 112018014042 A BR112018014042 A BR 112018014042A BR 112018014042 A2 BR112018014042 A2 BR 112018014042A2
Authority
BR
Brazil
Prior art keywords
virus
tilapia
orthomyxo
orthomyxo virus
vaccine
Prior art date
Application number
BR112018014042-2A
Other languages
English (en)
Inventor
Tal Shlomit
Dishon Arnon
Original Assignee
Kovax Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kovax Ltd. filed Critical Kovax Ltd.
Publication of BR112018014042A2 publication Critical patent/BR112018014042A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

vírus do tipo orthomyxo da tilápia. é aqui descrito o isolamento e caracterização de um vírus de rna de peixes recém-descoberto. métodos para a detecção do vírus isolado, uma vacina de vírus vivos atenuados e uma vacina do vírus inativado também são descritos.
BR112018014042-2A 2016-01-10 2017-01-10 vírus do tipo orthomyxo da tilápia. BR112018014042A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662276873P 2016-01-10 2016-01-10
US62/276,873 2016-01-10
US201662352570P 2016-06-21 2016-06-21
US62/352,570 2016-06-21
PCT/IL2017/050027 WO2017118989A1 (en) 2016-01-10 2017-01-10 Orthomyxo-like virus of tilapia

Publications (1)

Publication Number Publication Date
BR112018014042A2 true BR112018014042A2 (pt) 2019-02-12

Family

ID=59274499

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018014042-2A BR112018014042A2 (pt) 2016-01-10 2017-01-10 vírus do tipo orthomyxo da tilápia.

Country Status (6)

Country Link
EP (1) EP3400007A4 (pt)
CN (1) CN108778324A (pt)
BR (1) BR112018014042A2 (pt)
CO (1) CO2018008288A2 (pt)
MX (1) MX2018008529A (pt)
WO (1) WO2017118989A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108624718A (zh) * 2018-06-20 2018-10-09 上海海洋大学 恒温实时检测罗非鱼湖病毒的rpa试剂盒及其专用引物和探针
CN112194710A (zh) * 2020-08-19 2021-01-08 佛山科学技术学院 罗非鱼湖病毒s8基因编码的重组蛋白、由其制备的抗体及应用
NL2028806B1 (en) * 2021-07-22 2022-06-03 Univ Northwest A&F Tilv-2 protein or gene encoding tilv-2 protein in preparation of subunit vaccine against tilapia lake virus
CN113755645B (zh) * 2021-09-30 2023-06-09 厦门海关技术中心 一种检测罗湖病毒的荧光定量rt-pcr引物对和探针，试剂盒和检测方法
CN113718061B (zh) * 2021-09-30 2023-06-09 厦门海关技术中心 一种同时检测罗湖病毒和病毒性神经坏死病毒的双重rt-pcr的引物组，试剂盒和方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
BR112017012852A2 (pt) * 2014-12-15 2018-01-09 The Trustees Of Columbia University In The City Of New York novo vírus de tilápia e usos do mesmo

Also Published As

Publication number Publication date
WO2017118989A1 (en) 2017-07-13
EP3400007A1 (en) 2018-11-14
MX2018008529A (es) 2019-06-06
EP3400007A4 (en) 2019-08-28
CO2018008288A2 (es) 2018-08-21
CN108778324A (zh) 2018-11-09

Similar Documents

Publication Publication Date Title
BR112018014042A2 (pt) vírus do tipo orthomyxo da tilápia.
PH12017500858A1 (en) Mocrocyclic peptides useful as immunomodulators
EA201891087A1 (ru) Ингибиторы ret
EA201691993A1 (ru) Вакцина к вирусу эпидемической диареи свиней
BR112018005779A2 (pt) repressores de htt e usos dos mesmos
BR112017008165A2 (pt) anticorpos de domínio único direcionados contra antígenos intracelulares
EA201790532A1 (ru) Способы и композиции для ослабления иммунных ответов против вирусного вектора для переноса
MX2017008160A (es) Inmunomoduladores.
DK3166634T3 (da) Nye vaccinesammensætninger til epidemisk svine-diarrévirus
CO2017007105A2 (es) Nuevos virus de tilapia
EA201691945A1 (ru) Антитела к гемагглютинину вируса гриппа типа b и способы их применения
BR112016025819A2 (pt) vetores de vírus adeno-associados para o tratamento de doenças de depósito lisossômico
EA201692541A1 (ru) Вакцины против вируса гриппа и их применения
MX2017007196A (es) Fibroblastos de embrion de pollo inmortalizados.
EA201791095A1 (ru) Способ лечения рака
BR112017013568A2 (pt) compostos bicíclicos fundidos para o tratamento de doenças
BR112015025748A2 (pt) construção de dna para imunomodulação, composição farmacêutica, vacina, e uso de uma construção de dna
PE20170440A1 (es) Derivados de isoindolina
CU24580B1 (es) Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas
NZ739260A (en) Inactivated canine influenza vaccines and methods of making and uses thereof
DK3501535T3 (da) Profylaktisk eller terapeutisk fremgangsmåde til svinepidemi-diarrévirus, vaccine og vaccinekit
EA201790517A1 (ru) Способы и композиции для индуцирования защитного иммунитета против филовирусной инфекции
CL2017000151A1 (es) Derivados de piridona
MY179251A (en) Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development
MX2018014955A (es) Vacunas atenuadas vivas del virus de la influenza equina.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: ABIC BIOLOGICAL LABORATORIES LTD. (IL)

B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired
B350 Update of information on the portal [chapter 15.35 patent gazette]